Advertisement

Characteristics of the wm Substrain of BALB/c Mice

  • W. H. Murphy
  • G. L. Bolgos
Chapter
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 122)

Abstract

Our substrain (Staats 1976) of BALB/cwm mice originated with MacDowell who provided it to Professor J.T. Syverton at The University of Minnesota,viz., the BALB/csy substrain. It is still maintained there by Professor D.W. Watson. The C58/sy substrain was obtained from MacDowell at the same time. The first major publication reporting the experimental use of the BALB/csy substrain dates to October 1952 (Werder 1953). The early pedigree records have been lost but I estimate that the BALB/c mice were obtained from MacDowell in 1950. I assumed responsibility for maintaining them as an inbred strain in 1952 when they were designated the BALB/cwm substrain. I moved both the BALB/cwm and C5 8/wm substrains to The University of Michigan in January of 1958. The BALB/cwm substrain at that time was at generations F-100 through F-104. The C58/wm strain was at generations Fill through F114. Both strains were renumbered at generation F1 when moved to Michigan so that they could be distinguished from the stocks left at Minnesota. Each of the strains has been maintained as separate closed colonies since 1952 and have not been directly exposed to other mice since then. They now are at F generations of approximately 350.

Keywords

Natl Cancer Inst Inbred Strain Inbred Mouse Lymph Node Preparation Mycoplasma Fermentans 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Freter R, Stauffer E, Cleleven D, Holdeman LV, Moore WEC (1983) Continuous-flow cultures as in vitro models of the ecology of large intestinal flora. Infect Immun 39: 666–675PubMedGoogle Scholar
  2. Gabridge MG, Abrams GD, Murphy WH (1972) Lethal toxicity of Mycoplasma fermentans for mice. J Inf Dis 125: 153–160CrossRefGoogle Scholar
  3. Han IH, Johnson AG, Murphy WH (1969) Protection of C58 mice by normal tissues against transplantable leukemia, line Ib, J Natl Cancer Inst 42: 815–824PubMedGoogle Scholar
  4. Katz DH (1977) The allogeneic effect on immune responses. Academic Press, New York, p 482Google Scholar
  5. Law LL (1980) Changes in tumor-specific antigen expression during passage in vitro and in vivo of newly derived methylcholanthrene-induced sarcomas of BALB/c mice. Int J Cancer 25: 251–259PubMedCrossRefGoogle Scholar
  6. Lukasewycz OA, Martinez D, Murphy WH (1975) Immune mechanisms in leukemia: Evaluation of immunocompetent cell populations. J Immunol 114: 1491–1496PubMedGoogle Scholar
  7. Lukasewycz OA, Duffey PS, Murphy WH (1976) Immune mechanisms in leukemia: Protective capacity of the major lymphoid cell compartments. J Immunol 116: 976–981PubMedGoogle Scholar
  8. Martin WJ, Imamura M (1980) Variable expression of histocompatibility antigens on tumor cells. Cancer Immunol Immunother 8: 219–223CrossRefGoogle Scholar
  9. Morris RE, Bentley DM, Ciraolo GM (1981) Quantitation of tumor antigen expression on the surface of malignant line lb lymphocytes by immuno-electron microscopy. J Natl Cancer Inst 66: 111–119PubMedGoogle Scholar
  10. Murphy Jr WH, Watson DW (1957) Susceptibility of inbred mice to group A streptococcal infection. Proc Soc Exp Biol Med 94: 755–758PubMedGoogle Scholar
  11. Murphy Jr WH, Syverton JT (1961) Relative immunologic capacity of leukemic and low-leukemic strains of mice to resist infection. Cancer Res 21: 921–928PubMedGoogle Scholar
  12. Murphy WH, Bullis C, Heyn R, Zarafonetis CJD (1970) Isolation of mycoplasma from leukemic and nonleukemic patients. J Natl Cancer Inst 45: 243–251PubMedGoogle Scholar
  13. Murphy WH, Urnovitz HB, Maryanski JL, Abrams GD (1978) Characterization of transplantable leukemia WEHI-3B in syngeneic BALB/c mice. Proc Soc Exp Biol Med 157: 556–564PubMedGoogle Scholar
  14. Pease LR, Abrams GD, Murphy WH (1982) Fv-1 restriction of age-dependent paralytic lactic dehydrogenase virus infection. Virology 117: 29–37PubMedCrossRefGoogle Scholar
  15. Plata EJ, Murphy WH (1972) Growth and hematologic properties of the BALB/wm strain of inbred mice. Lab Animal Sci 22: 712–720Google Scholar
  16. Plata EJ, Abell MR, Murphy WH (1973) Incidence of leukemoid disease in mice by Mycoplasma fermentans. J Inf Dis 128:588–597CrossRefGoogle Scholar
  17. Staats J (1976) Standardized nomenclature for inbred strains of mice: sixth listing. Cancer Res 36: 4333–4377PubMedGoogle Scholar
  18. Tennant JR (1962) Derivation of a murine lymphoid leukemia virus. J Natl Cancer Inst 28: 1291–1303PubMedGoogle Scholar
  19. Urnovitz HB, Murphy WH (1979) Relative effectiveness of methods for immunizing BALB/cwm mice to transplantable myelomonocytic leukemia. Leuk Res 3: 329–339PubMedCrossRefGoogle Scholar
  20. Walker EB, Lanier LL, Warner NL (1982) Characterization and functional properties of tumor cell lines in accessory cell replacement assays. J Immunol 128: 852–859PubMedGoogle Scholar
  21. Warner NL, Moore MAS, Metcalf D (1969) A transplantable myelomonocytic leukemia in BALB/c mice: Cytology, karyotype, and muramidase content. J Natl Cancer Inst 43: 963–982PubMedGoogle Scholar
  22. Werder AA, Friedman J, MacDowell EC, Syverton JT (1953) The combined effects of cortisone and Roentgen radiation upon natural and induced resistance to homoiotransplantation of mouse leukemia, line lb. Cancer Res 13: 158–164PubMedGoogle Scholar
  23. Willoughby DS, Watson DW (1964) Host-parasite relationships among group A streptococci. II. Influence of sex on the susceptibility of inbred mice toward streptococcal infection. J Bacteriol 87: 1457–1461PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1985

Authors and Affiliations

  • W. H. Murphy
  • G. L. Bolgos

There are no affiliations available

Personalised recommendations